Microbiome Therapeutics Market Size to Hit $813.38 Million, Globally, by 2030 - Exclusive Report by The Insight Partners
10 nov. 2023 05h43 HE
|
The Insight Partners
Pune, India, Nov. 10, 2023 (GLOBE NEWSWIRE) -- Microbiome therapeutics, also referred to as microbiome-based therapies or interventions, are medical procedures that try to use the human microbiome's...
L’Alliance Promotion Microbiote accueille Ferring Pharmaceuticals, Pelican Health et Polepharma en tant que nouveaux membres
09 nov. 2023 10h00 HE
|
ALLIANCE PROMOTION MICROBIOTE
Lyon- France – 9 novembre 2023 – L’Alliance Promotion Microbiote (APM), acteur majeur dédié au développement, à la production et à la commercialisation d’innovations thérapeutiques basées sur le...
Alliance Promotion Microbiote To Welcome Ferring Pharmaceuticals, Pelican Health and Polepharma as New Members
09 nov. 2023 10h00 HE
|
ALLIANCE PROMOTION MICROBIOTE
Lyon – France, November 9th, 2023 – Alliance Promotion Microbiote (APM), a leading player dedicated to the development, the production, and the commercialization of therapeutic innovations based on...
Human Microbiome Market to hit USD 6.5 billion by 2032, says Global Market Insights Inc.
31 oct. 2023 07h30 HE
|
Global Market Insights Inc.
Selbyville, Delaware, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Human Microbiome Market size will be worth over USD 6.5 billion by 2032. In the current era of scientific advancement, understanding the...
Growing Prevalence of Mental Health Disorders and Advancements in Medical Technology Drive the Global Psychobiotics Market to 2033
11 oct. 2023 04h28 HE
|
Research and Markets
Dublin, Oct. 11, 2023 (GLOBE NEWSWIRE) -- The "Psychobiotics Market By Psychotropic Agent, By Form, By Application, and by Region - Global Forecast to 2023-2033" report has been added to ...
Axial Therapeutics Announces Completion of Enrollment in Global Phase 2b Clinical Trial for AB-2004 for Irritability Associated with Autism
26 sept. 2023 08h00 HE
|
Axial Therapeutics
– Topline clinical data anticipated in 1Q 2024 – – First-in-class small molecule therapeutic targets the microbiome gut-brain axis and its role in autism, offering a potential alternative to...
Global Live Biotherapeutic Products and Microbiome CDMO Market 2023-2029: Biose Industrie and List Biological Laboratories Shape Diabetes Application Market Share
10 août 2023 06h08 HE
|
Research and Markets
Dublin, Aug. 10, 2023 (GLOBE NEWSWIRE) -- The "Global Live Biotherapeutic Products And Microbiome CDMO Market Size, Share & Industry Trends Analysis Report By Application (C.difficile, Crohns...
Microbiome Technologies for Nutraceuticals and Personal Care: Technology and Application Analysis Research Report 2023
09 août 2023 04h53 HE
|
Research and Markets
Dublin, Aug. 09, 2023 (GLOBE NEWSWIRE) -- The "Microbiome Technologies for Nutraceuticals and Personal Care: Technology and Application Analysis" report has been added to ResearchAndMarkets.com's...
Stellar Expansion Predicted for Global Microbiome Sequencing Services Market as New Drug (IND) Requirements for Fecal Microbiota and Technological Innovations Offer Immense Opportunities
17 juil. 2023 05h28 HE
|
Research and Markets
Dublin, July 17, 2023 (GLOBE NEWSWIRE) -- The "Global Microbiome Sequencing Services Market (2023-2028) by Technology, Laboratory, Research, Products & Services, Application, End-User, Geography...
EnteroBiotix appoints Elmar Schnee as Executive Chairman
17 juil. 2023 03h00 HE
|
EnteroBiotix
GLASGOW, Scotland, July 17, 2023 (GLOBE NEWSWIRE) -- EnteroBiotix Limited (“EBX”), a clinical stage company with the premier platform for full-spectrum microbiome therapeutics, today announced the...